Home > Quotes > DXR

Daxor Corporation Stock Quote & Summary Data

Get DXR Alerts
*Delayed - data as of Jan. 28, 2015  -  Find a broker to begin trading DXR now
Exchange: AMEX
Industry: Health Care
Community Rating:
View:    DXR Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
1 Year Target
Today's High /Low  / 
Share Volume
90 Day Avg. Daily Volume This is the average share volume for the past 50 trading days, for NASDAQ stocks and 90 trading days for Non-NASDAQ stocks. This field allows you to compare today's trading to the average daily volume. 5,395
Previous Close $ 6.91
52 Week High/Low $ 8.90 / $ 5.65
Market cap “Market Capitalization” is a measure of the estimated value of the common equity securities of the company or their equivalent. It does not include securities convertible into the common equity securities. “Market Capitalization” is derived from the last sale price for the displayed class of listed securities and the total number of shares outstanding for both listed and unlisted securities (as applicable). NASDAQ does not use this value to determine compliance with the listing requirements. $ 25,616,370
Annualized dividend $ 0.20
Ex Dividend Date Dec. 5, 2013
Dividend Payment Date Dec. 27, 2013
Current Yield 2.89 %
Special Dividend $ 0.03
Special Dividend Date Dec. 4, 2014
Special Dividend Payment Date Dec. 26, 2014
Beta 0.51

Intraday Chart

Company Description (as filed with the SEC)

Daxor Corporation is a medical device manufacturing company which provides additional biotechnology services. Daxor Corporation was originally incorporated in New York State as Iatric Corporation in May 1971 for cryobanking services and continues these services through its wholly-owned subsidiary, Scientific Medical Systems. In October 1971, the name Iatric Corporation was changed to Idant Corporation. In May 1973, the name Idant Corporation was changed to Daxor Corporation. Our principal executive offices are located at 350 Fifth Avenue, Suite 7120, New York, NY 10118. The “Investor Relations” section of our website provides free copies of our annual reports on Form 10-K, our quarterly reports on Form 10-Q, and any current reports on Form 8-K, Forms 3, 4 and 5. For the past 16 years, the Company’s major focus has been the creation and development of the BVA-100 ® Blood Volume Analyzer, an instrument that rapidly and accurately measures human blood volume.  ... More ...  

Research Brokers before you trade

Want to trade FX?